Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study
Access status:
Open Access
Type
ArticleAuthor/s
Dodd, Rachael HCvejic, Erin
Bell, Katy J.L.
Black, Kirsten
Bateson, Deborah
Smith, Megan A
Mac, Olivia A
McCaffery, Kirsten
Abstract
The objective of this study was to investigate framing of active surveillance as a management option for cervical intraepithelial neoplasia (CIN)2 in women of childbearing age.
We conducted a between-subjects factorial (2 × 2) randomised experiment. Women aged 25–40 living in ...
See moreThe objective of this study was to investigate framing of active surveillance as a management option for cervical intraepithelial neoplasia (CIN)2 in women of childbearing age. We conducted a between-subjects factorial (2 × 2) randomised experiment. Women aged 25–40 living in Australia were presented with the same hypothetical pathway of testing human papillomavirus (HPV)-positive, high-grade cytology and a diagnosis of CIN2, through an online survey. They were randomised to one of four groups to evaluate the effects of (i) framing (method of explaining resolution of abnormal cells) and (ii) inclusion of an overtreatment statement (included versus not). Primary outcome was management choice following the scenario: active surveillance or surgery.
See less
See moreThe objective of this study was to investigate framing of active surveillance as a management option for cervical intraepithelial neoplasia (CIN)2 in women of childbearing age. We conducted a between-subjects factorial (2 × 2) randomised experiment. Women aged 25–40 living in Australia were presented with the same hypothetical pathway of testing human papillomavirus (HPV)-positive, high-grade cytology and a diagnosis of CIN2, through an online survey. They were randomised to one of four groups to evaluate the effects of (i) framing (method of explaining resolution of abnormal cells) and (ii) inclusion of an overtreatment statement (included versus not). Primary outcome was management choice following the scenario: active surveillance or surgery.
See less
Date
2021Source title
Gynecologic OncologyVolume
161Issue
1Publisher
ElsevierFunding information
NHMRC 197589
NHMRC 1174523
NHMRC 1159491
NHMRC 1121110
Cancer Institute NSW 181561
Licence
Copyright All Rights ReservedFaculty/School
Faculty of Medicine and Health, Sydney School of Public HealthShare